Abstract
Background
3D‐printing enables the production of anthropomorphic breast phantoms for assessing image quality in digital mammography (DM) and breast tomosynthesis (DBT). 3D‐printing materials must be selected carefully to mimic breast tissue attenuation for clinical spectra.
Purpose
This study investigates the impact on the effective X‐ray attenuation coefficient (µeff ) of polymer formulation and dopants (e.g., colorants) used in 3D‐printing materials. It also analyses the impact on their equivalent glandular ratios (BR) relative to commercial materials (CIRS).
Methods
Five base polymers (PLA, ABS, PETG, HIPS, RESIN) were selected among the catalogue of five manufacturers. A collection of nineteen variants (base polymer + color) was 3D‐printed as step‐wedges with thicknesses (t) from 0.5 to 5.5 cm and imaged on a clinical mammography system (DM: W/Rh with the anti‐scatter grid, DBT: W/Al without grid, at 27, 29 and 31 kVp). The µeff(t) values were derived from the mean pixel value measured at each step of the logarithmically transformed images. As reference, µeff values were measured for the CIRS materials with well‐known BR. A two‐parameter empirical model was used to fit the values as: µeff(t) = µ0 /(1+kt), where µ0 corresponds to µeff at thickness tending to zero, and k is the decrease rate with thickness due to beam hardening and scatter. The impact of dopants on polymer attenuation was evaluated by analyzing both µeff and µ0 values. Based on µ0–BR relationships of CIRS materials, the corresponding BR values were computed for the investigated materials.
Results
For all acquisition conditions, some color variants of 3D‐printed materials with the same base polymer exhibit noticeable differences in µeff , independently of the thickness, particularly for DM. For this modality, the maximum differences within µeff values of materials sharing polymer base decreased by 62% for PLA‐based, 44% for PETG‐based and 30% for ABS‐based materials, when the thickness increases from 1.5 to 5.5 cm. For DBT, a lower variability of µeff values was observed. The materials best mimicking purely glandular and adipose tissues were selected based on µeff , µ0 and BR results. Specifically, relative differences in µ0 (averaged across kVp), reported as paired values (DM, DBT) were: (−3%, +1%) and (−1%, +4%) for PLA crystal silver and PLA blue versus CIRS with BR = 100% (glandular tissue); (+3%, +1%) for ABS white versus CIRS with BR = 0% (adipose tissue). According to the BR values derived for all acquisition conditions, PLA blue and PLA crystal silver mimicked glandular tissue (BR: 101%–109%, 95%–100%, respectively), while ABS white mimicked adipose tissue (BR: −2% to 8%). PETG translucent blue and RESIN corresponded to intermediate glandular ratios (BR ≈ 50%–70%).
Conclusion
3D‐printed materials sharing the same polymer base can exhibit substantially different attenuation for DM/DBT spectra, resulting in different BR equivalences due to formulation variations (e.g., pigments and dopants). Therefore, phantom developers should not rely solely on base polymer designations and declared density when selecting materials for production of breast phantoms; instead, the attenuation of each specific formulation needs to be verified and periodically re‐evaluated under the intended mammography conditions.
Keywords: 3D‐printing, digital breast tomosynthesis, digital mammography, effective attenuation coefficients
1. INTRODUCTION
Conventional image quality evaluation in breast X‑ray imaging relies on simple test phantoms with test objects embedded in homogeneous backgrounds, which are well established for routine quality control primarily characterizing the technical performance of the imaging system. 1 However, this technical image quality assessment does not necessarily reflect the clinical image quality that determines how reliably breast lesions can be detected and characterized. 1 In addition, digital breast tomosynthesis (DBT) and dedicated breast CT (bCT) were developed to overcome key limitations of digital mammography (DM). 2 However, the advantages of these modalities cannot be fully evaluated with conventional phantoms, which do not reproduce realistic three‑dimensional breast anatomy or the complex background texture against which lesions must be detected. 3 , 4 , 5 , 6 Consequently, there is a growing need for anthropomorphic phantoms that reproduce complex breast tissue structures and generate realistic image texture similar to that seen in clinical images. 1 , 3 , 4 , 7
3D printing technologies are increasingly impacting medical physics through a wide range of applications, from diagnostic radiology and nuclear medicine to radiotherapy. 8 , 9 By enabling layer‑by‑layer fabrication of complex geometries from digital models, they offer great flexibility in shape, internal structure, and material selection while remaining relatively inexpensive and accessible. These characteristics make 3D‐printing a cost‐effective production method for anthropomorphic phantoms dedicated to image quality and dosimetry evaluation, among other uses in medical physics. 5 , 6 , 7 Besides achieving realistic anatomical structures, the printing materials must also exhibit X‑ray attenuation properties compatible with the breast tissues, under the beam qualities used in digital mammography (DM) and DBT. Commercial polymers (filaments and resins) employed in fused deposition modelling (FDM) and stereolithography (SLA) are readily available off the shelf, but their detailed composition, additives and pigments are usually not disclosed by manufacturers. These characteristics can influence their X‐ray attenuation, and materials with the same polymer base can present a wide performance range, as investigated in other imaging modalities such as CT. 10 Several studies have characterized the attenuation of common 3D‑printing polymers such as PLA, PETG and ABS under different X‑ray beam qualities, including CT beams, standardized radiographic spectra (RQR 3–10), mammography spectra and synchrotron‑generated monoenergetic beams. 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 In particular, measurements with mammography beam qualities (RQR 2‑M and 4‑M, Mo/Mo 28–35 kVp) 17 and monoenergetic synchrotron radiation in the 14–36 keV range 18 have shown that different commercial filaments of the same base polymer can exhibit different attenuation properties.
In a previous study, 19 an experimental methodology was proposed and validated to determine the effective attenuation coefficients (µeff ) of a set of 3D‐printed polymers using the clinical X‐ray beams of DM‐DBT systems. In addition, µeff values were also determined for CIRS materials (Sun Nuclear, Mirion Medical Co., Melbourne, FL, USA), that are widely accepted as equivalent breast tissue materials. 20 CIRS plates are widely used as reference materials because they are formulated to reproduce the mass attenuation and glandular ratio (BR) of standard breast compositions from BR 100/0 (100% glandular) up to BR 0/100 (100% adipose) and intermediate BR values. Comparing the measured µeff values of the 3D printing polymers and CIRS materials provided a rough estimate of the equivalent BR for each polymer. For an in‐depth analysis of the influence of beam hardening and scattering properties on the measured µeff values, they were fitted to an empirical two‐parameter (µ0, k) model. Based on the relationships between µ0 and BR of CIRS materials, the equivalent BR value of the polymers can be derived. 19
The aim of this work is to investigate the impact of pigments and other dopants used in commercial 3D printing polymers which modify their elemental composition and densities, on the µeff values measured for clinical spectra emitted by DM‐DBT systems as well as on their equivalent glandular ratios benchmarked against commercial well characterized breast equivalent materials.
2. METHODS
2.1. 3D‐printing methodology and step‐wedge phantom design
Nineteen commercial polymers from five manufacturers were included in this study representing five polymer classes (PLA‐, ABS‐, PETG‐, HIPS‐based, as well as a photopolymer RESIN) in different color variants (see Table 1). All these materials are commonly used in the production of 3D‐printed breast phantoms.
TABLE 1.
Set of polymer bases and variants analyzed. Nominal ρ corresponds to the density value specified by the manufacturer and measured ρ (uncertainty: 0.01 g/cm3) to the values measured for printed samples.
|
Polymer base |
Polymer variant (s) |
Measured ρ (g/cm3) |
Nominal ρ (g/cm3) |
Manufacturer |
|---|---|---|---|---|
| PLA | crystal silver | 1.23 | 1.24 |
BCN3D (BCN3D Technologies Inc. Barcelona, Spain) |
| jade white | 1.16 | BambuLab (Shenzhen Tuozhu Technology Co., Ltd., Shenzhen, China) | ||
| bambu green | 1.20 | |||
| pink; black; blue | 1.22 | |||
| red; blue grey | 1.23 | |||
| grey | 1.24 | |||
| ABS | black | 0.99 | 1.05 | |
| white; silver | 1.03 | |||
| natural | 1.04 | 1.04 |
BCN3D (BCN3D Technologies Inc. Barcelona, Spain) |
|
| ABS+ natural | 1.05 | 1.06 | eSun (Shenzhen Esun Industrial Co., Ltd., Shenzhen, China) | |
| PETG | translucent blue; red | 1.26 | 1.27 | |
| translucent grey | 1.23 | |||
| RESIN | clear | 1.21 | 1.21 | Formlabs (Formlabs Inc., Somerville, MA, USA) |
| HIPS | white | 1.03 | 1.04 | Fiberlogy (Fiberlogy SA, Brzezie, Poland) |
Step‐wedges of the different polymers were printed using two FDM printers, a BCN3D Sigma R19 (BCN3D Technologies Inc., Barcelona, Spain) and a Bambu Lab X1 Carbon (Shenzhen Tuozhu Technology Co., Ltd., Shenzhen, China). The SLA printer was a Form 3BL (Formlabs Inc., Somerville, MA, USA). For each polymer variant, printing temperature, nozzle diameter, layer height, line width and infill were fine‐tuned to optimize print quality avoiding issues like under‑/over‑extrusion, poor adhesion and nozzle clogging. All FDM polymers were printed with the highest possible infill setting (99% for BambuLab X1 Carbon, 100% for BCN3D Sigma) and using overlapping lines to minimize internal voids. The SLA resin was printed according to manufacturer specifications. Densities of the printed step‐wedges were measured gravimetrically with an uncertainty of 0.01 g/cm3 and compared with nominal values provided by the manufacturer (see Table 1).
The step‑wedges were designed with a base area of 1.5×10.0 cm2 and eight steps with nominal thicknesses of 0.5, 1.0, 1.5, 2.0, 3.0, 3.5, 4.0 and 5.5 cm, so that multiple thicknesses could be evaluated in a single exposure. The maximum step thickness was selected based on the typically used in the design of breast phantoms (commercial and research‐purpose) for image quality assessment. 1 Furthermore, this value corresponds to the most frequently reported in both breast screening and dose assessment studies.
2.2. DM and DBT imaging
Step‑wedges were imaged individually on a Hologic 3Dimensions system (Hologic Inc., Marlborough, MA, USA), positioning the step‐wedges with the thickest step at the frontal side of the breast support table, where X‑ray fluence is the highest. The images of the step‐wedges were obtained by manually selecting the kilovolts (27, 29, and 31 kVp) in accordance with those chosen by the automatic exposure control (AEC) for compressed breast thicknesses between 3.5 cm and 6.0 cm in clinical practice. This range corresponds to the most frequent breast thicknesses encountered in patient examinations on the system, if the step‐wedge thicknesses are considered. For DM acquisitions, a W/Rh target/filter combination was used with the anti‑scatter grid in place, whereas for DBT a W/Al target/filter was used without the grid. The W/Ag target/filter combination for DM, although available, was not used because a previous work 19 showed attenuation values comparable to W/Rh. The appropriate mAs for each material and spectrum was first determined from exposures with the AEC sensor positioned under the thickest step of the wedge. However, for some of the most attenuating polymers and certain acquisition conditions, the mAs could not be selected by the AEC as it exceeded the internally established mAs limits. Thus, for these cases, the position of the AEC sensor was selected under the next‐thickest step. Then, the images of the step‐wedges were acquired manually selecting the mAs value closest to those determined by the AEC. Three for processing 2D images and three DBT series with tube fixed at 0° (quality control mode) were acquired, using only the central DBT projection for analysis. The pixel size for both DM and DBT images was 0.07 mm. For each acquisition condition, additional flat‑field images (no step‐wedge in place) and dark‑field images (2 mm of lead shielding on the detector at minimal exposure) were acquired. All for‑processing images were dark‐field and flat‐field corrected, averaged for each exposure condition and logarithmically transformed.
2.3. Effective attenuation coefficients (µeff ) for 3D‐printed and CIRS materials
Effective attenuation coefficients (µeff ) were derived from the mean pixel value measured in 0.9 × 1.0 cm2 ROIs centered at each step of the logarithmically transformed images. The uncertainty of µeff was obtained by error propagation, accounting for the standard deviation of the pixel values within the same ROI and the uncertainty of the measured step thickness. As reference, we use the µeff values measured in a previous work 19 for CIRS materials with the following glandular/adipose ratios (BR): 0/100, 30/70, 50/50, 70/30 and 100/0.
For each 3D‐printed material and exposure condition, µeff values were fitted to a two‑parameter empirical model: µeff (t) = µ0 / (1 + k t) using weighted non‐linear least squares regression analysis. µ0 represents the effective attenuation coefficient for thickness tending to zero and k characterizes the decrease rate with thickness of µeff due to beam hardening and scatter. Thus, this fit yields an attenuation coefficient µ0 that is independent of material thickness facilitating comparison between different materials, including comparison with the CIRS materials. This model was previously validated for a smaller set of polymers and for the CIRS and PMMA materials using DM/DBT spectra, providing goodness‑of‑fit values R2 > 0.99, 19 and was therefore applied in the present work. The robustness of the fits to this model was evaluated by recomputing µeff values for each thickness, material and acquisition condition by substituting the corresponding parameters (µ0 , k) into this model. The relative differences between the model‑derived and the experimental µeff values were calculated across all thicknesses, materials and acquisition conditions.
For the CIRS materials, quadratic relationships of the form BR = aµ0 2 + bµ0 + c were established for each acquisition condition. The BR value of polymers for each target/filter/kVp combination was then obtained by replacing its µ0 value into the corresponding quadratic relationship. The overall uncertainties of the derived BR values were obtained by propagating the uncertainties of the fit parameters a, b and c, together with the uncertainty of µ0 .
3. RESULTS
3.1. Effective attenuation coefficient values of the set of printing polymers and benchmark against commercial materials
Figure 1 displays the effective attenuation coefficients as a function of thickness for all the 3D‐printed materials evaluated together with the closest equivalent CIRS material, when possible, for benchmarking. As expected, across all DM and DBT conditions, the effective attenuation coefficient (µeff ) decreased monotonically with thickness for every material, as illustrated in Figure 1 for 29 kVp, with analogous trends observed at 27 and 31 kVp.
FIGURE 1.

Effective attenuation coefficients (µeff ) as a function of thickness of reference materials (open markers) and printed polymers (filled markers) at 29 kVp for DM: W/Rh with the anti‐scatter grid in place (a–c) and for DBT: W/Al without the grid (d–f). Error bars correspond to (± 1σ) bands.
The following subsets of polymers are ranked based on their µeff values relative to those obtained for the CIRS materials: polymers with µeff consistently higher than those of CIRS 70/30 (PLA group), between those of CIRS 50/50 and CIRS 100/0 (PETG–RESIN group), and lower than those of CIRS 50/50 (ABS–HIPS group). Figure 1 also shows that, independently of the thickness, some color variants of 3D‐printed materials with the same base polymer exhibit noticeable differences in µeff , particularly for DM spectra. For PLA‐, PETG‐, and ABS‐based materials, the maximum differences between the µeff values obtained for DM decreased by 62%, 44%, and 30%, respectively, when the thickness increases from 1.5 to 5.5 cm. In DBT, the maximum differences in µeff were lower (27%, 20% and 22% for PLA‐, PETG‐ and ABS‐based materials, respectively).
The highest differences for each polymer group were between for PLA grey and PLA crystal silver, between PETG red and PETG translucent blue, and between ABS+ and ABS black. Furthermore, important differences were identified between µeff values of materials sharing the same manufacturer, base polymer and measured printed density (Table 1) with clearly different µeff were identified (e.g., PLA black and blue, ABS white and silver, PETG red and translucent blue). In contrast, µeff values of some PLA‐based polymers exhibited a discrepancy lower than 5% across all thicknesses and acquisition conditions: PLA bambu green, black, pink, red and blue grey as one subset and PLA blue and crystal silver as another. Plots in Figure 1 show that µeff values of PLA crystal silver and PLA blue matched those of BR 100/0, ABS white corresponded to those of BR 0/100, while PETG translucent blue matched both BR 70/30 and PMMA.
3.2. Fits to the two parameter (µ0, k) empirical model
Median of R2 values obtained in the fittings of µeff to the two‑parameter empirical model are in the range 0.92–0.99 for 112 out of 114 fits. The lowest R2 values were found for HIPS (0.86 and 0.81, for W/Rh @ 27 kVp and 29 kVp, respectively). Over all thicknesses, materials and acquisition conditions, the relative differences between model‑derived and experimental µeff values ranged from about −2% to +3% excluding the values for 0.5 cm, as it can be seen in Figure 2. No clear trends were observed with respect to thickness, and no differences were found between DM and DBT or among the different kVp values. For the 0.5 cm thickness, larger discrepancies were observed, with relative differences ranging from −6% to +3%. Overall, for DM acquisitions, the model‐derived µeff values tended to be lower than the experimental measurements.
FIGURE 2.

Relative differences (%) between experimental (µexp ) and model‐derived (µmodel ) effective attenuation coefficient values for all thicknesses, materials and acquisition conditions.
The values for µ0 (µeff at thickness tending to zero) derived from the fits decreased by about 17% when switching from DM to DBT for all the polymers. Considering polymers with the same base, maximum relative differences in µ0 were 25%, 10% and 22% for PLA, PETG and ABS considering all acquisition conditions. Values of the parameter k (decrease rate of µeff with thickness) averaged for all acquisition conditions follow the same order as µ0 (i.e., kABS < kPETG < kPLA ). Moreover, when switching from DM to DBT, the corresponding k values were reduced by approximately 30% to 45%, depending on the base polymer.
To determine the equivalence between CIRS materials and polymers, the relative differences in µ0 between each polymer (and PMMA) and each CIRS material were calculated for all acquisition conditions. Figure 3 presents in a bar‐graph, the relative differences of each 3D‐printed material with the nearest CIRS reference material (smallest differences) for each acquisition condition. Such graph facilitates to identify visually the materials that overall are good surrogate candidates for a given benchmarked breast composition for different beam qualities and modality. The bars for 3D‐printed materials exhibiting the largest relative differences (i.e., > +5% from BR 100/0 and < −5% from BR 0/100) were excluded from Figure 3 to enhance those candidates best mimicking the CIRS materials. This applied to PLA grey, PLA jade white, and HIPS.
FIGURE 3.

Relative difference between µ0 values of polymers (and PMMA*) and the CIRS materials (bar color) for DM (left) and DBT (right) and for all kVp values (hatch patterns). For each polymer, the smallest relative difference in µ0 with respect to the CIRS reference material is only shown. PLA jade white, PLA grey and HIPS are not included due to their large relative differences. Error bars correspond to (± 1σ) bands.
As it can be seen in Figure 3, the relative differences in µ0 between most PLA filaments and BR 100/0, averaged across kVp, were greater than 8% for DM and ranged from 5% to 13% for DBT. For most ABS filaments, the differences with respect BR 0/100 were smallest than 10% and 8% for DM and DBT, respectively. The smallest relative differences (averaged across kVp values) reported in the paired form (DM, DBT) were as follows: PLA crystal silver (−3%, +1%) and PLA blue (−1%, +4%) with respect to BR 100/0 and, respectively, making both suitable as glandular‑like surrogates; ABS white (+3%, +1%) with respect to BR 0/100, confirming its role as an appropriate surrogate for adipose tissue. In the intermediate attenuation range, PMMA, PETG translucent blue and the RESIN were generally close to BR 70/30. The CIRS equivalence of some 3D‐printed materials was spectrum‑dependent: ABS+ matched BR 50/50 for W/Rh at 31 kVp whilst was closer to BR 30/70 for W/Rh at 27 and 29 kVp (Figure 3); ABS silver corresponded to BR 30/70, except for W/Al at 27 kVp, where it matched BR 50/50; and the RESIN was consistent with BR 70/30 for all conditions except W/Rh at 27 kVp, where it mimicked to BR 50/50.
The equivalent glandular ratio (BR) of each polymer for each acquisition condition was deduced from the quadratic fits between µ0 and BR (BR = aµ0 2 + bµ0 + c) of CIRS materials. 19 The BR values of those polymers with µ0 far outside of the µ0 range of CIRS materials were not determined, as the quadratic fits would not be meaningful in these cases. The plots in Figure 4a,b show µ0 values as a function of the derived BR of each polymer for DM and DBT acquisitions. The nominal BR values of the CIRS materials are plotted as vertical dashed lines. The shaded bands around these lines represent the uncertainty in the BR values obtained when µ0 for CIRS are replaced into the quadratic relationship. As can be seen, these uncertainties for DBT were systematically larger than for DM, reflecting the higher µ0 uncertainties, but the overall clustering pattern of polymers relative to the CIRS BR ranges is preserved.
FIGURE 4.

µ0 values (a, b) and mAs selected by AEC (c, d) as a function of the glandular ratio (BR) of polymers for DM and DBT. The colour of symbols corresponds to the polymer, and its shape, to the kVp value. Dashed lines indicate the nominal BR values of the CIRS materials, and the grey shaded bands represent the uncertainties in their BR values estimated from the fits. Error bars correspond to (± 1σ). Most vertical error bars are not visible). The mAs values correspond to those automatically chosen with the AEC sensor under the thickest step.
The equivalent BR values for the selected 3D‐printed polymers are summarized in Table 2, expressed as BR intervals covering all tube kVp investigated. Moving from DM to DBT, most polymers showed a shift towards higher BR values, indicating a relative increase in glandular‑equivalent attenuation under tomosynthesis conditions, although the magnitude of this shift depended on both the base polymer and even colour. As illustrated in Figure 4, some PLA and ABS colour variants, even from the same manufacturer, product line and in some instances even identical measured density, occupied widely separated positions along the BR axis, demonstrating that different polymer formulations can correspond to markedly different breast‑equivalent compositions (e.g., ABS white and silver, PETG translucent blue and red).
TABLE 2.
Ranges of equivalent glandular ratio BR (%) across all investigated kVp values of selected 3D‐printed materials for DM and DBT.
| ABS | RESIN | PET | PLA | ||||||
|---|---|---|---|---|---|---|---|---|---|
| white | grey | ABS+ | clear | blue grey | translucent blue | red | crystal silver | navy blue | |
| DM | 1–8 | 26–33 | 38–42 | 59–65 | 65–69 | 78–82 | 81–86 | 95–96 | 106–109 |
| DBT | −2–6 | 33–41 | 47–57 | 68–71 | 68–76 | 77–84 | 86–88 | 95–100 | 101–103 |
As expected, the mAs values selected by the AEC to acquire the step‐wedge images increase with the derived BR of the 3D‐printed polymers (see Figure 4c,d), reflecting the higher attenuation of the materials according with the AEC functioning of the mammography system of this study.
The results in Table 2 indicate that ABS white behaves as an adipose‑like surrogate, whereas PLA blue and PLA crystal silver were consistent with glandular‐like compositions. Furthermore, ABS grey, ABS+, PETG variants and the clear RESIN could be considered surrogates for intermediate BR values.
4. DISCUSSION
This study demonstrates that the effective attenuation coefficient (µeff ) of 3D‐printed materials sharing the polymer base depends on their specific formulation under clinical imaging conditions in mammography and DBT. These values directly measured for different material thicknesses reinforce and extend previous observations of color‑ and additive‑dependent attenuation in nominally identical polymers. 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 Polymers are generally grouped into ABS‐HIPS, PETG‐RESIN and PLA according to increasing attenuation, with ABS usually classified as an adipose surrogate and PLA, PETG or photopolymer resins being used as higher‑attenuation materials. 10 , 11 , 12 , 13 , 14 , 15 , 17 , 18 However, when working directly with clinical DM/DBT beams and comparing all measurements with well‐established CIRS materials equivalent to breast tissue, it is observed a shift in X‑ray attenuation enough to change the breast‑tissue equivalence assigned to 3D‑printed materials. Therefore, the present work shows that base polymer designation is insufficient for the selection of materials to be used in the production of 3D‐printed breast phantoms.
At small thicknesses, polymers sharing the same base composition showed a large spread in µeff values, which indicates that formulation differences (including colorants and dopants) can substantially modulate attenuation under DM conditions. As thickness increases, this spread reduces, particularly for PLA‐based materials, suggesting that the relative influence of pigments and dopants on µeff becomes less critical for thicker slabs. Under DBT conditions the thickness‐dependent reduction in µeff variability is more moderate and similar across base polymers. This is consistent with the idea that scattered radiation partly damps the impact of colorants on the dispersion of µeff values across formulations.
The fit of values to the two‑parameter (µ0, k) empirical model showed median R2 ≈ 0.94 considering all polymers evaluated and across acquisition conditions. In addition, relative differences between model‐derived and experimental µeff values were around 2% for most of the cases (see Figure 3). This assures the robustness of the model as it yields consistent predictions.
On average, switching from DM (W/Rh with grid) to DBT (W/Al without grid) reduced µ0 by about 17%, whereas k decreased by approximately 30%–45% depending on the base polymer, which is consistent with differences in effective spectra and scatter conditions between both modalities. 2 , 10 , 18 , 19 Within each polymer base group, the spread in µ0 (≈25% for PLA, ≈10% for PETG and ≈22% for ABS) is compatible with the effect of pigments, dopants and fillers reported in attenuation characterizations performed with CT and RQR beams. 11 , 12 , 13 , 14 , 15 , 17 , 18 For example, materials such as PLA black and PLA blue, ABS white and ABS silver, or PETG red and PETG translucent blue displayed clearly different µ0 despite sharing manufacturer, base polymer and measured printed density. This indicates that compositional differences at the formulation level affect X‐ray attenuation. 12 , 15 , 18
The derived BR values obtained using the quadratic µ0–BR relationships for CIRS materials 19 provide a direct route to translate polymer attenuation into equivalent breast compositions, clearly seen in Figure 4a–b and Table 2. For the CIRS materials, the differences between the derived‐model and nominal BR values range from −2 to 1, considering all materials and acquisition conditions. In addition, the R2 values of the quadratic model were higher than 0.991. The polymer clusters around BR values derived from µ0–BR plots (Figure 4a–b) hold when considering the mAs automatically selected by the AEC of the mammography system. This agreement supports the use of the BR values derived from the polymers as a meaningful surrogate for BR in terms of AEC response (see Figure 4c,d).
Based on the results obtained for µeff , µ0 and BR values, despite the number of polymers considered, only PLA crystal silver and PLA navy blue behave as glandular‑like surrogates compatible with BR 100/0, whereas PLA grey and PLA jade white exhibit supra‑glandular attenuation. The latter ones are therefore more appropriate as high‑contrast lesion surrogates. ABS white was confirmed as a surrogate for adipose tissue (BR close to 0/100), while other ABS variants and HIPS fell below adipose‑equivalent attenuation. They would be more suited to represent structures with lower attenuation than standard adipose tissue. PETG translucent blue showed attenuation comparable to BR 70/30 and to PMMA, supporting their use as intermediate tissue surrogates or to introduce background heterogeneities instead of a binary adipose/glandular model. 7
The µ0 and BR values of the 3D‐printed materials facilitates the selection of suitable candidates to produce multi‑material phantoms. The adipose‑, intermediate‑ and glandular‑like components could be chosen from specific, experimentally validated formulations rather than from generic designations such as “PLA” or “ABS”. Furthermore, the experimental methodology based on direct measurements using mammography systems provides a reliable way of assessing the suitability of polymers.
Several limitations should be considered when interpreting the results presented in this study. First, all measurements were performed on a single DM/DBT system using specific W/Rh and W/Al spectra and three kVp settings. Second, only five base polymers and nineteen commercial formulations were investigated, all printed with the highest possible infill setting. Other materials (e.g., nylon, TPU, highly filled composites), alternative infill patterns, or different printing parameters could alter attenuation and, consequently, reported BR values.
These limitations nevertheless delineate clear directions for future work that should extend the characterization to additional DM/DBT systems and beam qualities. It would also be valuable to monitor ageing and batch‑to‑batch variability in 3D‐printed materials or phantoms by performing periodic checks of attenuation properties over time and across production batches, to detect potential changes in filament formulation introduced in the manufacturing process.
5. CONCLUSION
This work shows that 3D‑printed polymers with the same nominal base composition can exhibit markedly different X‑ray attenuation under clinical DM and DBT spectra, as a consequence of the addition of dopants or colors. Therefore, they must be treated as different materials for breast phantom design. By characterizing nineteen commercial formulations relative to CIRS breast tissue‑equivalent plates, only a limited subset—ABS white (adipose‑like), PLA blue and PLA crystal silver (glandular‑like) and selected PETG/RESIN variants (intermediate)—was found to match specific CIRS glandular ratios, while other color variants within the same product lines deviated substantially from these ratios. These findings imply that phantom developers cannot rely solely on base polymer designations when selecting materials for breast phantoms, but should instead verify attenuation for each specific formulation, and periodically recheck it, under the intended mammography conditions. With the present dataset, multi‑material phantoms can be constructed using validated adipose‑, intermediate‑ and glandular‑like surrogates, and more attenuating formulations can be deliberately assigned as lesion surrogates, thereby supporting more realistic and reproducible task‑based image quality assessment in DM and DBT.
AUTHOR CONTRIBUTIONS
Adrián Belarra: development of the original idea; experimental measurements; analysis of experimental results; writing of the paper; paper revision. Irene Hernández‐Girón: writing of the paper; paper revision. María Castillo: experimental measurements; writing of the paper; paper revision. Peter Homolka: writing of the paper; paper revision. Margarita Chevalier: experimental measurements; writing of the paper; paper revision; project management and scientific support.
FUNDING INFORMATION
This work was supported by the Spanish Ministry of Science and Innovation under grants PID 2021–123390OB‐C21 and PID 2021–123390OB‐C22.
CONFLICT OF INTEREST STATEMENT
All authors declare no conflicts of interest.
ETHICS STATEMENT
This work did not involve human participants, identifiable patient data, or animal experiments, and therefore did not require institutional review board or ethics committee approval.
ACKNOWLEDGMENTS
The authors acknowledge the Centro de Patología de la Mama for their valuable collaboration in image acquisitions that supported the experimental measurements of this study.
REFERENCES
- 1. Sarno A, Valero C, Tucciariello RM, Dukov N, Costa PR, Tomal A. Physical and digital phantoms for 2D and 3D x‐ray breast imaging: review on the state‐of‐the‐art and future prospects. Rad Phys Chem. 2022;204:110715. doi:10.1016/j.radphyschem.2022.110715 [Google Scholar]
- 2. Boone JM, Nelson TR, Lindfors KK, Seibert JA. Dedicated breast CT: radiation dose and image quality evaluation. Radiology. 2001;221(3):657‐667. doi:10.1148/radiol.2213010334 [DOI] [PubMed] [Google Scholar]
- 3. Bliznakova K. The advent of anthropomorphic three‐dimensional breast phantoms for X‐ray imaging. Phys Med. 2020;79:145‐161. doi:10.1016/j.ejmp.2020.11.025 [DOI] [PubMed] [Google Scholar]
- 4. Salomon E, Unger E, Homolka P, et al. Technical note: realization and uncertainty analysis for an adjustable 3D structured breast phantom in digital breast tomosynthesis. MedPhys. 2023;50(8):4816‐4824. doi:10.1002/mp.16600 [DOI] [PubMed] [Google Scholar]
- 5. He Y, Liu Y, Dyer BA, et al. 3D‐printed breast phantom for multi‐purpose and multi‐modality imaging. Quan Imaging Med Surg. 2019;9(1):63‐74. doi:10.21037/qims.2019.01.05 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Rossman AH, Catenacci M, Zhao C, et al. Three‐dimensionally‐printed anthropomorphic physical phantom for mammography and digital breast tomosynthesis with custom materials, lesions, and uniform quality control region. J Med Imag. 2019;6(02):1. doi:10.1117/1.jmi.6.2.021604 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Varallo A, Sarno A, Castriconi R, et al. Fabrication of 3D printed patient‐derived anthropomorphic breast phantoms for mammography and digital breast tomosynthesis: imaging assessment with clinical X‐ray spectra. Phys Med. 2022;98:88‐97. doi:10.1016/j.ejmp.2022.04.006 [DOI] [PubMed] [Google Scholar]
- 8. Filippou V, Tsoumpas C. Recent advances on the development of phantoms using 3D printing for imaging with CT, MRI, PET, SPECT, and ultrasound. Med Phys. 2018;45(9):e740‐e760. doi:10.1002/mp.13058 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Tino R, Yeo A, Leary M, Brandt M, Kron T. A systematic review on 3D‐Printed imaging and dosimetry phantoms in radiation therapy. Technol Cancer Res & Treat. 2019;18:1533033819870208. doi:10.1177/1533033819870208 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Hofmann T, Buschmann M, Belarra A, et al. Mimicking tissues in 3D‐Printed radiology phantoms: brand, product, and color of printing filaments matter!. Polymers. 2026;18(7):851. doi:10.3390/polym18070851 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Ma X, Figl M, Unger E, Buschmann M, Homolka P. X‐ray attenuation of bone, soft and adipose tissue in CT from 70 to 140 kV and comparison with 3D printable additive manufacturing materials. Sci Rep. 2022;12(1):14580. doi:10.1038/s41598‐022‐18741‐4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Hofmann T, Buschmann M, Homolka P. X‐ray attenuation properties of additive manufacturing and 3D printing materials for mimicking tissues in radiographic phantoms measured by CT from 70 to 140 kV: 2025 update. Biomimetics. 2026;11(3):202. doi:10.3390/biomimetics11030202 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Veneziani GR, Corrêa EL, Potiens MPA, Campos LL. Attenuation coefficient determination of printed ABS and PLA samples in diagnostic radiology standard beams. J Phys Conf Ser. 2016;733:012088. doi:10.1088/1742‐6596/733/1/012088 [Google Scholar]
- 14. Savi M, Villani D, Andrade MAB, Rodrigues O, Potiens MPA. Study on attenuation of 3D printing commercial filaments on standard X‐ray beams for dosimetry and tissue equivalence. Rad Phys Chem. 2021;182:109365. doi:10.1016/j.radphyschem.2021.109365 [Google Scholar]
- 15. Kunert P, Trinkl S, Giussani A, Reichert D, Brix G. Tissue equivalence of 3D printing materials with respect to attenuation and absorption of X‐rays used for diagnostic and interventional imaging. Med Phys. 2022;49(12):7766‐7778. doi:10.1002/mp.15987 [DOI] [PubMed] [Google Scholar]
- 16. Ivanov D, Bliznakova K, Buliev I, et al. Suitability of low density materials for 3D printing of physical breast phantoms. Phys Med Biol. 2018;63(17):175020. doi:10.1088/1361‐6560/aad315 [DOI] [PubMed] [Google Scholar]
- 17. Oliveira M, Savi M, Andrade M, et al. Attenuation properties of common 3D printed FFF plastics for mammographic applications. Braz J Radiat Sci. 2022;10(1):e1732. doi:10.15392/bjrs.v10i1.1732 [Google Scholar]
- 18. Mettivier G, Sarno A, Varallo A, Russo P. Attenuation coefficient in the energy range 14–36 keV of 3D printing materials for physical breast phantoms. Phys Med Biol. 2022;67(17):175012. doi:10.1088/1361‐6560/ac8966 [DOI] [PubMed] [Google Scholar]
- 19. Belarra A, Hernández‐Girón I, Garayoa J, et al. Experimental determination of effective X‐ray attenuation coefficients of 3D‐printed materials under clinical mammography spectra. Front Bioeng Biotechnol. 2026;13:1719551. doi:10.3389/fbioe.2025.1719551 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. CIRS Inc . Tissue equivalent materials for medical imaging phantoms: Technical data sheet (Norfolk, VA: CIRS‐Sun Nuclear; ). 2020. [Google Scholar]
